Breast reconstruction is a surgical procedure that restores breast shape and appearance after mastectomy or lumpectomy. There are two main types of breast reconstruction – implant-based and autologous tissue-based reconstruction using donor tissue. Breast reconstruction surgery offers physical, psychological, and social benefits to breast cancer patients undergoing mastectomy. The global Breast Reconstruction Market is estimated to be valued at US$ 901.3 Mn in 2023 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The demand for aesthetic reconstruction is elevating in the Breast Reconstruction Market. With the increasing focus on aesthetics, women are opting for breast reconstruction procedures not only for physical benefits but also for psychological wellbeing and confidence. This is increasing the demand for procedures offering a more natural look and feel like autologous reconstruction using the patient’s own tissues. Various prefabricated techniques are being adopted that decrease procedure time and improve cosmetic outcomes. These techniques involve creating an implant pocket and shaping the breast during mastectomy, thereby speeding recovery and optimizing aesthetic results. Advancements in reconstruction methods are fueling the growth of the Breast Reconstruction Market.
Breast reconstruction procedures are segmented into implant-based and autologous flap-based reconstruction procedures. Implant-based reconstruction using breast implants is the most commonly performed procedure globally, accounting for more than 70% of the breast reconstruction procedures. This is dominated by implant-based reconstruction owing to advantages like shorter surgery time and recovery period compared to autologous procedures. However, autologous procedures using abdominal tissues (TRAM or DIEP flaps) provide a more natural look and feel to reconstructed breast compared to implants.
The Global Breast Reconstruction Market Demand is expected to witness high growth over the forecast period of 2023 to 2030, driven by factors such as the rising incidence of breast cancer cases and increasing awareness about breast reconstruction options.
Regional analysis: North America currently dominates the global breast reconstruction market, accounting for over 40% of the market share in 2024. This is attributed to factors such as the higher incidence of breast cancer, presence of favorable reimbursement policies, and growing awareness about breast reconstruction procedures in the region. Asia Pacific is expected to witness the fastest growth during the forecast period due to improving access to advanced treatments, rising medical tourism, and growing awareness.
Key players: The global breast reconstruction market is highly competitive with presence of several global and local players. Key players operating in the breast reconstruction market are Polytech Health & Aesthetics GmbH, Allergan, Mentor Worldwide LLC (Johnson & Johnson), Sientra Inc., and GC Aesthetics. These companies are focused on new product launches and partnerships with hospitals and plastic surgeons to strengthen their presence across major markets. For instance, in 2023 Allergan launched anatomical soft-touch breast implants NATRELLE INSPIRA SoftTouch.
Source: Coherent Market Insights, Public sources, Desk research
We have leveraged AI tools to mine information and compile it